B3Impact of metabolic syndrome on clinical outcome of castration resistant prostate cancer (CRPC) patients treated with abiraterone and enzalutamide
Conteduca, V, Caffo, O, Galli, L, Maugeri, A, Scarpi, E, Maines, F, Chiuri, V E, Lolli, C, Kinspergher, S, Schepisi, G, Santoni, M, Santini, D, Fratino, L, Burgio, S L, Salvi, S, Menna, C, de Giorgi,Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx423.002
Date:
October, 2017
File:
PDF, 73 KB
english, 2017